Research Grants 7 show all


$3M
2003

$8M
2004

$8.7M
2005

$8.6M
2006

$8.4M
2007

Patents 197show all

  • 103
    A61K - Preparations for medical, dental, or toilet purposes
  • 72
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 57
    Y02A - Technologies for adaptation to climate change
  • 19
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 16
    C07H - Sugars
  • 14
    C07D - Heterocyclic compounds
  • 5
    B82Y - Specific uses or applications of nanostructures
  • 5
    C12N - Microorganisms or enzymes
  • 4
    C07C - Acyclic or carbocyclic compounds
  • 3
    A01N - Preservation of bodies of humans or animals or plants or parts thereof

Clinical Trials 33show all

16Phase 25Phase 15Phase 32Phase 2/Phase 31Other

SEC Filings show all


97
8-K

22
10-Q

7
10-K

4
D

1
S-1

Contact Information

Durham, NC
United States

SEC Form D Funding Events

DateOfferedSoldType
2011-02-15$68,749,994$45,000,010Equity, Option to Acquire, Security to be Acquired
2009-08-07$16,145,011$16,130,011Equity
2007-03-12Unknown Unknown Other (Paper Filing)

Key Executives

  • George Painter, Ph.D.
    Executive Officer, Director
  • Graham K. Crooke, M.B.B.S.
    Director
  • Martha J. Demski
    Director
  • Edward E. Penhoet, Ph.D.
    Director
  • Seth A. Rudnick, M.D.
    Director
  • Timothy J. Wollaeger
    Director
  • Kenneth I. Moch
    Executive Officer
  • Merrick Almond, Ph.D.
    Executive Officer
  • Rosemary O'Mahony, Ph.D.
    Executive Officer
  • George Painter, Ph.D
    Executive Officer, Director
  • Gwendolyn P. Painter, M.D., MPH
    Executive Officer
  • Farah Champsi
    Director
  • Arthur M. Pappas
    Director
  • James Niedel
    Director